Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SambaNova Systems is an artificial intelligence (AI) innovation company that provides a full-stack platform for generative AI and deep learning. The company's technology is built around the Reconfigurable Dataflow Unit (RDU), a specialized processor designed to accelerate data-intensive workloads more efficiently than traditional GPUs. In the healthcare and life sciences sectors, SambaNova's platform is utilized to accelerate drug discovery, improve medical imaging resolution, and analyze complex genomic data. Their SambaNova Suite offers enterprise-grade AI solutions that allow organizations to deploy large language models (LLMs) and other advanced AI capabilities on-premises or in a secure cloud environment. By providing integrated hardware and software, the company enables researchers to process massive datasets that are critical for modern precision medicine and bioinformatics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SambaNova Systems.